Making diagnostic testing accessible on a global scale
Fungal infections are the hidden crisis of our times, killing 150 people each hour and causing misery to millions more.4 For example, nearly a billion people have a fungal infection of the skin.6 Despite this, fungal infections are often misunderstood, under-appreciated and receive less public awareness than diseases caused by bacteria, viruses and parasites – such as TB or malaria.
The size of the problem
Individuals with impaired immune systems, such as cancer and HIV patients, or those who have undergone bone marrow or organ transplants, are most at risk of suffering from an invasive fungal infection.7
In the developing world, diagnostic tests for fungal diseases are often not done, or not available, so doctors treat blind, if at all, leading to high infection rates. This can cause discomfort, anxiety and productivity loss, which has a disproportionate impact on economies.4
How OLM can have a global impact
Due to a lack of fast and accurate diagnostic tests, the prescription of antimicrobial drugs is rarely based on an accurate diagnostics.6
At OLM Diagnostics, our rapid diagnostic kits are inexpensive and require no additional equipment. OLM is providing doctors with the tools to reduce the number of antimicrobials used to slow down antimicrobial resistance.
OLM is at the forefront of rapid fungal diagnostic testing set to become mainstream clinical diagnostic practice in hospitals worldwide.
To see the UK picture click here
Chronic pulmonary aspergillosis (CPA) prevalence
Recurrent vulvo-vaginal candidiasis (rVVC) prevalence
Join our diagnostic-led-approach
We know that many of the best ideas can come from collaboration. We are therefore committed to working with partners to deliver innovative new products.